NCT01494753View on ClinicalTrials.gov

Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Primary Open Angle Glaucoma
Interventions
DRUG

T2345

One drop at 8.00pm.

DRUG

Prostaglandin

One drop at 8.00pm.

Sponsors

Lead Sponsor

Laboratoires Thea
All Listed Sponsors
lead

Laboratoires Thea

INDUSTRY